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High throughput experiments can be used to spatially and temporally investigate the many factors
that regulate cell differentiation. We have developed a micro-bioreactor array (MBA) that is
fabricated using soft lithography and contains twelve independent micro-bioreactors perfused
with culture medium. The MBA enables cultivation of cells that are either attached to substrates
or encapsulated in hydrogels, at variable levels of hydrodynamic shear, and with automated image
analysis of the expression of cell differentiation markers. The flow and mass transport in the MBA
were characterized by computational fluid dynamic (CFD) modeling. The representative MBA
configurations were validated using the C2C12 cell line, primary rat cardiac myocytes and human
embryonic stem cells (hESCs) (lines H09 and H13). To illustrate the utility of the MBA for
controlled studies of hESCs, we established correlations between the expression of smooth muscle
actin and cell density for three different flow configurations.
Introduction
The cellular microenvironment, also termed a ‘‘cell niche’’,
controls and regulates stem cell fate.1,2 Historically, the term
‘‘niche’’ was used to describe the stem cell location,3 the
components of the microenvironment surrounding the cells,
and the biochemical or electrical signals produced by the
support cells.4,5 The niche functions as a physical anchor and
generates a number of extrinsic factors that control cell fate.
From an engineering perspective, we may define the stem cell
niche as a microenvironment with multiple regulatory factors,
molecular and physical, that change in space and time and
govern stem cell behavior. Replicating in vitro the ‘‘cell niche’’
normally found in vivo would likely help understand and
ultimately control the signaling pathways that regulate cell
fate, and help utilize the potential of stem cells in regenerative
medicine.6–8 Each of the standard cell culture methods have
advantages but also limitations. Well plates are easy to use, but
they are suitable only for studies of molecular factors and
cannot provide physical regulatory factors. Also, well plates
operate essentially batch-wise, with the composition of
medium constantly changing between the two medium replace-
ments. In contrast, cell culture bioreactors can provide
perfusion of medium,9–13 control medium composition and
thereby support the cultivation of high cell densities, including
cultures of human embryonic stem cells (hESCs)14,15 and
embryoid bodies.16 However, the operating volumes of
bioreactors are larger than those of well plates, which is a
serious limitation in studies involving the use of expensive
media components. Microscale approaches can potentially
overcome both of these limitations.13,17–24
Soft lithography techniques, pioneered by Whitesides and
colleagues,25 are inexpensive and relatively facile, and have
found widespread application in bioseparation processes,26,27
micropatterning of cells and biomaterials,28,29 cell-based
assays,30,31 and cell culture devices.32–34 Early applications
of cell culture devices relate to hepatocytes where microscale
features provide a reasonable analog for the microstructure
of the liver.35 More recently, microfluidic platforms of
interconnected chambers have been proposed as ‘‘living cell
arrays’’ for studying gene expression36 and co-culture.21
In the existing microfluidic systems for stem cell differentia-
tion, the individual chambers are not independent, as medium
is distributed across one or more columns/rows of the array,
leading to the cross-talk between the cells. By enclosing each
chamber, this problem may be avoided, although it now
becomes more difficult to control the individual chambers
without resorting to an integrated valving system.13
Additionally, direct access to the cell growth surface makes it
possible to apply coatings and uniformly seed the cells.
Here we propose micro-bioreactor arrays (MBAs) designed
to address some of the limitations discussed above. MBAs
are a hybrid between a bioreactor (represented by each
individual culture well) and a microfluidic device (represented
by the system providing independent flow of medium to each
individual culture well). The MBA device combines the
advantages of multi-well plates (small volume, high through-
put, independent culture wells) and perfusion bioreactors
(steady-state conditions, enhanced mass transport, application
of physical signals). To take advantage of imaging com-
patibility of this device, we also developed an automated image
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analysis routine that enables fast and unbiased analysis of
nuclear and cytoplasmic differentiation markers.
We use the term ‘‘micro-bioreactor’’ because 12 culture
wells, 3.5 mm in diameter 6 2 mm deep, are located within a
device that is the size of a microscope slide (26 6 76 mm). Two
different configurations of the MBA were developed based on
computational flow modeling and analysis of mass transport:
MBA-bottom inlet/outlet (BIO; medium flows directly over
the substrate with attached cells) and MBA-middle inlet/outlet
(MIO; medium flows above the plane with the cells in a
monolayer or encapsulated in hydrogel). These MBA con-
figurations were validated for cultivations of the C2C12 cell
line, primary rat cardiac myocytes and hESCs (lines H09 and
H13). To illustrate the utility of the MBA for studies of hESCs,
we established quantitative correlations between the density of
hESCs differentiating into vascular lineages and the expression
of smooth muscle actin.
MBA design
The design requirements for the MBA were: (1) high
throughput experimentation with independent conditions for
each bioreactor well, and low consumption of reagents and
cells; (2) cultivation of cells in both the 2D setting (attached to
a substrate) and three dimensional (3D) setting (encapsulated
in hydrogel); (3) reproducible steady-state conditions in terms
of cell density, medium composition, levels of oxygen and
pH, flow regime, hydrodynamic shear and transport rates;
(4) accurate spatial-temporal control of the cell environment;
(5) in situ quantitative analysis of cell proliferation and
differentiation, by automated image analysis of differentiation
markers.
Fig. 1 shows the design of the system. The MBA is
fabricated using soft lithography techniques, has the footprint
of a standard microscope slide, and contains twelve indepen-
dent culture wells. The constituent elements are shown in a top
view (Fig. 1A): inlet (top, shown in red) and outlet (bottom
shown in yellow) ports, culture wells (orange), gas exchangers
(microfluidic channels between the inlet ports and the culture
wells), stream splitters (divide single inlet/outlet streams by
four), and the fluidic channels (connecting the inlets, gas
exchangers, culture wells and outlets).
The microfluidic channels are 100 mm high by 100 mm
wide. Gas exchangers (20 mm total length) are designed to
equilibrate the oxygen level and pH in each of the three inlet
streams of culture medium. A splitter then divides each of
these streams into four equal parts, resulting in a total of
twelve inlet streams leading into the twelve culture wells.
In this way, each MBA has three inlet/outlet ports and three
four-way splitters directing flow to the 4 6 3 array of culture
wells. The total length of the fluid paths leading into each well
is equivalent, and the pressure drop and velocity field are thus
also equivalent for each of the culture wells.
The diameter of each culture well (3.5 mm) was selected to
provide a small volume of medium (e.g., y30 ml for BIO
configuration) and the surface area (y10 mm2) large enough
for a statistically significant number of cells to adhere (y103).
With standard soft lithography, the height of the micro-
bioreactor chamber would be restricted to the thickness of the
photoresist, generally between 50 mm and 200 mm. For our
applications, this would result in three constraints: (i) limited
access to the cell chamber for surface coating, cell seeding, and
analysis, (ii) insufficient medium hold-up within the bioreactor
chamber for cell survival without perfusion, and (iii) relatively
high shear stresses for medium perfusion. For these reasons,
we chose to work with an ‘‘open’’ microfluidic device where
each chamber may be individually addressed (i.e., open) and
has a height equal to that of device. A removable gas
permeable membrane is used to enclose each chamber during
experimentation.
Fig. 1 MBA design. (A) The micro-bioreactor wells (3.5 mm in
diameter) are arranged in a 4 6 3 array (8 mm vertical and 7 mm
horizontal center-to-center spacing). The microfluidic channels are
100 mm wide by 100 mm high and deliver between 0.1–2.0 ml of
medium per day per bioreactor well. Each of three inlets delivers
medium (red) through the flow transducers to four wells (orange) via
microfluidic channels. Waste medium exits each bioreactor via a
separate set of channels (yellow). The devices are assembled from
layers of poly(dimethylsiloxane) (PDMS) and glass attached via
plasma treatment of both surfaces. (B) Two configurations were used.
A bottom inlet/outlet (BIO) configuration (left) consists of a glass
slide, a microfluidic layer, and a gas permeable membrane cover. A
middle inlet/outlet (MIO) configuration (right) has an additional layer
of PDMS with an array of wells inserted between the microfluidic layer
and the slide. The BIO and MIO configurations accommodate the
2D cultivation of cells attached to a substrate (glass with or without
additional coating); a thin layer of a photopolymerizable hydrogel
in the base of the MIO configuration wells allows 3D cultivation.
(C) Image of a single MBA with compression frame and fluidic
connections. (D) Experimental setup. MBAs and medium collectors
are placed in an incubator for temperature (37 uC) and gas com-
position (5% CO2) control. Medium reservoirs are maintained external
to the incubator in an ice bath. The syringes are affixed to a plate that
allows a second set of syringes filled with water to actuate plungers via
an external low-flow multi-channel syringe pump.











































Fig. 1B shows the two configurations of the MBA device
that were used in the present study. Configuration BIO
consists of a single layer of poly(dimethylsiloxane) (PDMS)
with replica molded microfluidic channels and is perforated
with an array of culture wells. The microfluidic channels are
placed on the glass slide, such that the medium enters and exits
the well at the bottom surface and flows directly over the
attached cells (Fig. 1B, left).
Configuration MIO has an additional layer of PDMS,
which (i) increases the depth of the culture well and (ii)
presents medium inlets and outlets in the middle plane (Fig. 1B,
right). As in the BIO configuration, the cells are cultured in a
monolayer formed on the glass slide (with or without coating),
with the main difference being a substantial reduction in
exposure to hydrodynamic shear by culturing the cells outside
the main plane of fluid flow. To accommodate the cultivation
of hESCs in a 3D setting, a thin layer of photopolymerizing
hydrogel may be added to the base of the wells in this
configuration. Since cells in vivo are typically surrounded on all
sides by extracellular matrix components,24,37,38 this approach
more closely mimics the in vivo environment. The compressive
stiffness of HA hydrogel can be varied from 0.5–50 kPA, by
varying the concentration of HA and the level of crosslinking.
The hydrogel layer experiences only a small level of shear
stress; it is thin enough (typically 200–500 mm) to avoid major
constraints in mass transfer and changes in flow patterns, yet
thick enough for the cells to mimic some aspects of their native
3D environment.
The use of thin hydrogels and medium perfusion provides
favorable conditions for encapsulation of hESCs in photo-
polymerizable hydrogels. First, the high surface to volume
ratio of hydrogel in the wells (20–50 cm2 cm23) allows for thin
film (minimal light attenuation with depth) assumptions to be
made. Also, medium perfusion efficiently removes any residual
non-polymerized reactants.
The gas permeable membrane that seals each of the MBA
chambers is held in place with a compression frame consisting
of an aluminium frame, a clear polycarbonate cover, and four
thumb screws (Fig. 1C). The experimental set-up is designed to
assure steady state conditions during the dynamic culture.
Each column of wells receives medium from one 10 ml syringe
placed on ice (to minimize protein degradation) and is
controlled with a syringe pump (Fig. 1D). Each outlet tube
from the MBA was connected to a discharge medium collector
placed y20 cm above the device, all within the incubator.
Operating conditions: flow and mass transport
To characterize the operating conditions of the MBA, we
evaluated the two configurations shown in Fig. 2B, in order to
establish predictive flow and mass transport correlations
for optimizing the conditions in the MBA. The large flow
resistance within the 100 mm microfluidic channels ensures
equivalence of flow conditions in the twelve individual micro-
bioreactor wells of the MBA. At the entrance and exit of each
well, the channel width is gradually increased to reach the
diameter of the well (1 : 35 ratio of diameters, 1 : 20 ratio
of heights), and minimize abrupt changes in fluid velocity.
With the gradual change in the effective channel size and the
dominance of viscous forces on the microscale, the flow field
should remain laminar and uniform. Fluid flow was evaluated
by solving the steady-state Navier–Stokes equations for
incompressible fluid. The 3D solutions for the BIO and MIO
configurations show that the pressure distribution within the
chambers are uniform, with .99% of the pressure drop occur-
ring at the inlet and the outlet to the chamber (Fig. 2 A–B).
The uniformity of flow is further supported by the magnitude
of the fluid velocity, which is very low throughout the culture
well. In the BIO configuration, the fluid velocity in a plane
50 mm above the cell culture surface is less than 10 mm s21 over
the entire surface area, and less than 3 mm s21 for 75% of
the area (Fig. 2C). At these low flow rates, the shear stress
is ,0.01 dyn cm22. In the MIO configuration, the fluid
velocity and shear stress are even lower (,0.01 mm s21,
,0.0001 dyn cm22, Fig. 2D). These simulations show that
both configurations operate at very low-shear, but with clear
differences (two orders of magnitude) in the values of fluid
velocity and hydrodynamic shear.
A semi-quantitative analysis of mass transport for each of
the two flow regimes was performed for two representative
molecules: oxygen (the most critical small molecule) and
albumin (a molecule representative of large growth factors)
(Fig. 2E–G). As expected, the thickness of the boundary layer
was lower for the BIO configuration, and the mass transport
coefficient was higher for oxygen than for albumin and higher
for the BIO than for the MIO configuration. The Peclet
number (Pe) is a measure of the relative contribution of
convection with respect to diffusion. At Pe. 1, mass transport
is dominated by convection, a situation associated with
efficient exchange of nutrients and metabolites between the
cells and culture media. In contrast, the dominance of
diffusion (Pe , 1) may be associated with the accumulation
of cell-secreted factors, hypoxia and changes in pH. The Pe
numbers for the MIO configuration strongly suggest that
diffusion dominates mass transport, whereas for the BIO
configuration, convection plays a much larger role with
diffusion only important for small molecules (oxygen) and
negligible for large molecules. This analysis demonstrates
the flexibility of an MBA approach for quantitative experi-
mentation. Through simple regulation of flow rate, chamber
height, and inlet/outlet configuration, a wide range of mass
transport regimes are attainable.
Validation of the MBA for representative cell types:
C2C12, rat cardiac myocytes and hESCs
To validate the utility of the MBA for controlled studies of cell
growth and differentiation, we selected three model systems
that are representative of the envisioned applications of this
device: C2C12 myoblast cell line (MIO, BIO), primary cardiac
myocytes derived from neonatal rat hearts (MIO, BIO), and
hESCs (MIO). These cell types have well defined differentia-
tion markers, and we have extensive experience in their
use in various 2D and 3D configurations.39–42 Fig. 3 shows
representative growth and differentiation data, at the time
points characteristic for each cell type.
C2C12 cells readily adhered to the glass micro-bioreactor
surface and formed spatially uniform monolayers with











































characteristically high cell densities over 7 days of culture
(Fig. 3A, a–c). Close inspection of the chamber outlet channel
revealed higher cell density with respect to the inlet channel
due to cell migration along the velocity field line (Fig. 3A, c).
This phenomenon was particularly noticeable within the
100 mm high outlet channel section of the MBA-BIO, where
the average velocity and shear stress are high (y100 mm s21
and y0.1 dyn cm22 at the flow rate of 1026 ml s21). Within
Fig. 2 Flow and mass transport conditions in the MBA. (A, B) Pressure distribution (color map) and velocity field (arrows) for BIO and MIO
configurations, respectively, obtained by finite element modeling (FEM) of fluid flow. (C, D) Fluid velocity in the plane 50 mm above the cell
culture surface (blue line) and shear stress along the centerline (circles) for the BIO and MIO configurations, respectively. Gray vertical lines
show the boundary of the MBA well. (E, F) Spatial distributions of oxygen concentration (color map), fluid velocity (arrows) and velocity
streamlines (lines) for the BIO and MIO configurations, respectively. (G) Calculated mass transport data for the BIO and MIO configurations,
for two representative molecules: oxygen (as a small critical nutrient) and albumin (representative of a large growth factor). Data correspond to
images (E, F).











































7–10 days, cells formed multinucleated myotubes that were
distributed throughout the culture well (Fig. 3A, d–e),
elongated and expressed smooth muscle actin (Fig. 3A, e–f).
Coating the chamber surfaces with collagen enabled neonatal
rat cardiac myocytes to adhere and subsequently form
spatially uniform monolayers (Fig. 3B, a–b). Cell viability,
morphology and phenotype were well maintained, as seen
by the expression of Troponin I. Spontaneous macroscopic
contractions demonstrated that the cells were functionally
active throughout the culture period.
The cultivation of hESCs turned out to be, as in most other
systems, significantly more challenging than that observed
for the other cell types. Similar to cardiac myocytes, hESCs
required uniform collagen coating of the substrate to obtain
even cell distribution (see Methods for details). The hESCs
were also cultured encapsulated in a thin layer of hydrogel
Fig. 3 Cultivation of three representative cell types (A) MBA-BIO system evaluation with C2C12 cell line. (a) Phase contrast image showing
homogenous distribution of C2C12 over the whole surface area (7 days, MBA-BIO configuration); cells in the outlet channel are shown on the
right. (b) Enlargement of the outlet channel of the chamber showing cell migration in the direction of fluid flow; only a few cells are present in the
inlet section (not shown). (c) Spatially homogeneous cell distribution (higher magnification image). (d) Cell differentiation into multinucleated
myotubes (arrows). (e) Immunostaining of C2C12 for Tropomyosin in the entire well (shown in red; nuclei are shown in blue) in the entire well. (f)
High magnification of the myotubes (Tropomyosin: red; nuclei: blue). (B) MBA-MIO system evaluation with primary neonatal rat cardiomyocytes
and hESCs. (a) Fluorescent immunostaining for Troponin I showing homogenous cardiomyocytes distribution at 4 days within MBA-MIO
configuration. (b) Higher magnification of Troponin I and DAPI immunostaining of cardiomyocytes. The staining shows the lack of differentiation
of the cardyomyocyte during the MBA culture. (c, d) Representative images of hESCs (4 days), (c) with and (d) without perfusion of culture
medium (green: live cells; red: dead cell nuclei). (e) Addition of 100 ng hVEGF resulted in hESC sprouting and elongation outside the colonies
(bright field image). (f) Sprouting cells expressed a-SMA, indicative of vascular differentiation (shown in red, confocal microscopy image).











































(hyaluronic acid, HA), a configuration that is 3D for the cells
but effectively 2D from the perspective of the bioreactor
operation.
For cultivation in a 2D setting (MIO), hESCs retained high
viability with all conditions (data not shown). For cultivation
in a 3D setting, medium perfusion affected the viability of
all cells studied and most prominently the viability of hESCs
(representative data for hESCs shown in Fig. 3B, c–d),
presumably due to the combination of enhanced transport at
the hydrogel surface and removal of any residual reagents
from hydrogel polymerization. After 4 days of culture, the
measured fractions of viable cells were 55 ¡ 10 and 67 ¡ 65
total cells for the static and perfused culture, respectively. To
induce vascular differentiation of the HA-encapsulated hESCs,
human vascular growth factor (hVEGF) was added to the
culture medium, which resulted in extensive cell sprouting and
a-smooth muscle actin (a-SMA) expression (Fig. 3B, e–f).
Taken together, these studies demonstrated that both MBA
configurations (BIO, MIO, Fig. 1) support the growth and
differentiation of healthy and viable cells.
Vascular differentiation of hESCs: effects of cell
density and flow configuration on SMA expression
The MBA system was designed for live imaging of culture
wells with optical and fluorescent microscopy. To take
advantage of this option in studies of hESCs, we developed a
simple automated system for image analysis that allows fast
and unbiased analysis of cell growth and differentiation.
Automated and semi-automated routines have been used to
measure other biological parameters, such as the spindle length
in a Drosophila cell line.43 The routine is similar, but not
identical (measurements of the length vs. the numbers of
positive cells). Fig. 4A shows a representative image of hESCs
differentiating into vascular lineages and labeled for a-SMA
(red), Oct4 (green) and DAPI (blue). A robust algorithm is
used to assess the expression of nuclear and cytoplasmic
markers in images of this kind.
To generate quantitative data, the positions of the individual
cells stained with DAPI are first determined for a given
view field. The expression of intranuclear (e.g., Oct4) and
Fig. 4 Effects of cell density and flow configuration on hESC differentiation within the MBA device. (A) A representative merged image of
cultured hESCs with immunofluorescent labels for a-SMA (red), Oct4 (green) and DAPI (blue). (B) Automated image analysis of cell
differentiation. Individual cells are identified by nuclear staining (DAPI) and the coordinates of nuclei are stored in a data matrix. The presence or
absence of a nuclear label (Oct4 is shown as an example) and cytoplasmic label (a-SMA is shown as an example) is identified for each identified cell.
Data are processed by a flow cytometer-like analysis, to obtain a dot plot or a histogram representing the intensity of a specific marker within the
cell population. (C) Examples of the immunofluorescence of SMA (red) and DAPI (blue) for hESCs cultured in three different flow configurations:
static MBA (left column: a, d, g), perfused MBA-MIO (middle column: b, e, h) and MBA-BIO (right column: c, f, i), three different cell densities:
60¡ 6 (top row: a, b, c), 160¡ 4 (middle row: d, e, f) and 314¡ 15 (bottom row: g, h, i). Scale bars: 200 mm. (D) The fraction of differentiated
cells was determined using the automated image analysis for each flow configuration for a range of cell densities observed over the time of the
culture. Data are plotted as the fraction of hESCs expressing a-SMA as a function of the total number of cells in the field (an index of cell density)
for each flow configuration. Vertical dotted lines correspond to the conditions in panels (C).











































cytoplasmic (e.g., a-SMA) markers is then tracked for each
individual cell, and represented in the form of a histogram or
a dot plot in a manner common to flow cytometry. Fig. 4B
shows a schematic description of the developed imaging
routine, which was utilized to probe the effects of cell density
and flow regime on hESC differentiation.
hESCs were cultured using the MBA-BIO and MBA-MIO
configurations, and a non-perfused MBA-BIO to serve as
a static control. Cell density varied from 3 6 102 to 3 6
104 cells cm22, corresponding to y30 to 3000 cells per well.
Vascular differentiation was evaluated by the expression of
a-SMA, using the imaging routine described above.
Fig. 4C shows representative images of cells stained for
a-SMA (red) and DAPI (blue), that were cultured using three
different flow configurations (static, BIO and MIO), The top,
middle and bottom rows of panels show images obtained
for low, medium and high cell density (60 ¡ 6, 160 ¡ 4 and
314 ¡ 15 cells per well, respectively).
In general, cells cultured in the MBA-BIO configuration (the
one with a higher level of shear) exhibited higher levels of
differentiation relative to the other two configurations (Fig. 4
C,D). This is consistent with the known role of hydrodynamic
shear in vascular differentiation.44
In all three configurations, the fraction of hESCs expressing
a-SMA increased as the cell density decreased (Fig. 4D). For
example, in the MIO configuration, the percent of cells
expressing a-SMA decreased from y23% to y2% as the cell
density increased from y200 cells cm22 to y10 000 cells cm22.
Cells cultured in the BIO configuration showed a similar trend,
at higher expression levels of a-SMA for comparable cell
densities (Fig. 4D). Interestingly, Oct4 was not dependent on
cellular density (data not shown). The fractional expression of
the a-SMA in hESC culture decreased linearly with the
logarithm of cell density for all three bioreactor configura-
tions. This graph summarizes the results from y70 individual
bioreactors for multiple MBA configurations. The automated
assay for quantification of cell differentiation markers,
presented here for the case of vascular differentiation of
hESCs in 2D culture, could be extended to 3D cultures of cells
and a variety of other differentiation markers.
This study demonstrated that the MBA could be used to
study the effects of culture parameters on hESC differentia-
tion, in a systematic manner and with only a minimal
consumption of cells and reagents. The image processing
routine used to assess the fractions of cells expressing
differentiation markers (SMA and Oct4 in this case) can be
considered an integral part of the proposed method.
Application of MBA in studies of hESCs
The MBA was designed to culture hESCs in a microarray
setting, under controlled conditions, with imaging compatibi-
lity, and only minimal consumption of cells and reagents.
hESCs are difficult to grow, require expensive medium and
reagents, and from a biological perspective, their complex
signaling networks and largely unknown regulatory factors
often result in data variability. The use of a system that
combines the advantages of microarrays (large numbers of
groups and replicates, small volumes) and bioreactors (tight
control of environmental conditions) with the automated
routines of image processing to assess cell differentiation can
largely improve the yield and quality of experimental data.
In general, the MBA shares many properties with other
microfluidic-based platforms: low consumption of media,
inexpensive fabrication, imaging compatibility, and high
throughput. However, MBAs also provide close control of
culture parameters (including hydrodynamic shear) in each
culture well. Additional practical advantages include open
access to the cell culture plane in each micro-bioreactor well, to
ease surface coating, cell seeding and staining procedures. This
allows for an easy translation of the existing biological
protocols already established for hESCs to use in MBA
formats, and a relatively straightforward use of existing liquid
handling-robotic systems and microplate readers.
Notably, each MBA well maintains its own set of steady-
state conditions via perfusion of culture medium in a single-
pass mode, and without interaction with other wells within the
same array. The medium at the outlet of each well is sent to the
waste instead of being recirculated back to the cells (as in most
perfused bioreactors). This way, there is no interaction
between the wells, and the experiments are not confounded
by paracrine signals being transferred downstream. In spite of
single-pass flow, the consumption of medium is minimal
because of the miniature size of the device. In studies of
vascular differentiation of hESCs, 70 data points were
generated over 4 days of culture using only 10 ml of medium.
One of our goals was to provide a uniform and controllable
hydrodynamic environment for all cells in the culture
chamber. The CFD-assisted design yielded two different
configurations—MBA-BIO and MBA-MIO—which exhibit
hydrodynamic shear stress that can be as low as ,0.1 and
,0.001 dyn cm22, respectively. Both values are significantly
below the threshold levels of shear stress that can affect the
cells (1–5 dyn cm22), a feature very useful for cultivation
of hESCs in a quiescent regime. On the other hand, if
hydrodynamic shear is needed (e.g., to mediate cell differentia-
tion) these levels can be increased by a simple increase of
fluid velocity. Also, the BIO and MIO configurations provide
different flow environments, and the experiments described
above show that the culture of hESCs in a BIO configuration
resulted in larger values of a-SMA-positive cells than culture in
the MIO configuration.
Methods
Fabrication of the MBA
The micro-bioreactor array was designed in a standard CAD
program (SolidWorks, Concord, MA, USA), and then
exported to Adobe Illustrator 9.0 (San Jose, CA, USA) for
printing as a transparency mask (5080 dpi, PageWorks,
Cambridge, MA, USA). The mask was used to prepare a
40 silicon wafer–SU-8 2100 master of the bioreactor image.
The processing guidelines of the photoresist manufacturer
were followed to achieve features with a uniform height of
100 mm.45
The actual bioreactor layers were replica molded46,47 by
pouring 35 ml of PDMS (Sylgard 184 Silicone Elastomer,
Ellsworth Adhesives, Germantown, WA, USA) over a master











































placed in a 150 mm Petri dish. Prior to this step, a thin layer of
hexamethyldisilane (Fluka, Buchs, Switzerland) was vacuum
deposited on the wafer surface to prevent adherence of the
PDMS. The fluidic connection ports were punched through
the PDMS with a 21-gauge stainless steel tube (0.635 mm ID,
0.81 mm OD, McMaster–Carr, Atlanta, GA, USA). In a similar
manner, the micro-bioreactor wells were cored out using a
3.5 mm punch (Fray Products Corp., Buffalo, NY, USA),
resulting in holes that were 3.35 mm in diameter. The layers of
PDMS and glass were irreversibly bonded after treatment with
vacuum gas plasma for 45 s (at 0.5 mbar and 50 W) (Harrick
Scientific, Pleasantville, NY, USA). After coating the bottom
surface of each well and seeding with cells, the entire bio-
reactor array was covered with a thin layer (0.2 mm) of PDMS.
The MBA layers were held in place by mechanical compression
via a frame consisting of an aluminium base, a polycarbonate
cover, and four thumbscrews. Small lengths of stainless steel
tubing (21-gauge, 10 mm length) were used to connect the
MBA ports to soft Tygon tubing (0.8 mm ID, 2.4 mm OD,
Cole Palmer, Vernon Hills, IL, USA). The medium flow rate
was controlled via a syringe pump, with an accuracy of
0.1 ml min21 (PHD, Harvard Apparatus, Holliston, MA, USA).
The culture medium was kept at 4 uC, while the entire MBA
device was kept in an incubator (NAPCO, Winchester VA,
USA) at standard conditions (37 uC, 95% humidity, 5% CO2).
Hydrodynamic simulation
The Navier–Stokes equations for incompressible fluids were
solved using Comsol Multiphysics software (Burlington, MA,
USA) to obtain a flow field within the micro-bioreactor well
for the BIO and MIO configurations. The 3D domain of the
micro-bioreactor well was meshed using four-node tetrahedron
finite elements with a maximum mesh size of 300 mm.
Coarsening and refining of the mesh space grid ensured
solutions independent of the spatial discretization.
The inlet boundary condition was set for a fully developed
velocity profile (calculated on the basis of flow rate), while a
zero pressure condition was imposed on the outlet and non-slip
boundary condition set for channel and bioreactor walls.
Assumption of longitudinal symmetry allowed solving the
equations for only one half of the channel and chamber, thus
minimizing computational time.
The medium viscosity and density values for DMEM
medium with 5% FCS were taken from the literature.48 As a
check on the validity of the simulation, the shear stress within
the uniform rectangular channels was calculated from an
approximation of the analytical solution for flow between
parallel plates, t = 6mQ/bh2 where m is the dynamic viscosity
of the medium (0.0077 dyn s cm22), Q is the flow rate
(5 6 1026 ml s21), b is the channel width (0.01 cm), and
h is the channel height (0.01 cm). The calculated value of
0.058 dyn cm22 compares well to the result obtained by finite
element modeling of the flow in the channel (y0.07 dyn cm22
at the position 0.32 cm from center of the well, Fig. 2C).
Mass transport calculations
To obtain concentration profiles within the micro-bioreactor
wells for the BIO and MIO configurations, the mass balance
equations for a convective diffusive regime were solved using
Comsol Multiphysics software (Burlington, MA, USA). Fluid
velocity profiles were obtained from the three dimensional
solution. The concentration of 1 mM was used as a boundary
condition at the inlet; zero concentration was imposed as a
boundary condition at the cell surface. The Re and Pe numbers
were then calculated using standard equations and literature
values of diffusion coefficients for each solute.
Cell culture
C2C12 myoblast cells (murine, American Type Culture
Collection) were grown to confluency in growth medium
(DMEM with 20% fetal bovine serum, FBS). Cells were
trypsinized, counted, and 2000 cells were added to each MBA
well. After 12 h, medium perfusion was initiated at a flow rate
of 0.3 ml min21 (0.432 ml day21), which corresponds to
0.075 ml min21 per bioreactor. Perfusion medium contained
low serum levels (2% FBS), to induce myogenic differentiation.
Experimental methods with primary cells (cardiomyocytes)
were similar to those with C2C12 line except that cells were
seeded at 1000 cells per well and the culture medium contained
10% FBS. Details on cardiomyocyte isolation from 2-day old
neonatal Sprague Dawley rats can be found elsewhere.49
Non-differentiated hESCs (lines H9 and H13; passage
20–35) (WiCell Research Institute, Madison, WI, USA) were
grown on inactivated mouse embryonic fibroblasts (Chemicon
International, Temecula, CA, USA) in growth medium con-
sisting of 80% KnockOut DMEM, supplemented with 20%
KnockOut Serum replacement, 4 ng ml21 basic Fibroblast
Growth Factor, 1 mM L-glutamine, 0.1 mM b-mercaptoetha-
nol, and 1% non-essential amino acid stock (all from
Invitrogen Corp., Carlsbad, CA, USA). hESCs were passaged
to a new feeder layer using 1 mg ml21 type IV collagenase
(Invitrogen Corp., Carlsbad, CA, USA). For 3D studies,
hESCs were removed from the feeder layer by incubation with
collagenase for 20–30 min. For 2D studies, hESCs were
removed from MEFs by incubation with EDTA (Promega),
with 5% FCS, for 20 min, followed by separation into single
cells using a 40 mm mesh strainer (Falcon). For 2D studies,
the glass surface of each MBA chamber was treated with
a solution of 4% 3-aminopropyltrimethoxysilane (Sigma–
Aldrich, St. Louis, MO, USA) in acetone for 15 min. Each
well was then coated with 0.05 mg ml21 collagen IV (R&D
Systems, Minneapolis, MN, USA) for 1 h at room temp. The
cells were seeded at concentrations of 103, 36103, 56103, and
104 cells per well. Medium perfusion was started 24 h after cell
seeding to allow sufficient time for cell attachment.
Hydrogel preparation and hESC microencapsulation
For 3D studies, we utilized previously developed photo-
crosslinkable methacrylated HA hydrogels.50–52 We recently
showed that these HA hydrogels support the propagation of
undifferentiated hESCs and the initiation of vascular differen-
tiation.53 For hydrogel formation, methacrylated HA was
dissolved in PBS containing 0.05 wt% 2-methyl-1-[4-(hydroxy-
ethoxy)phenyl]-2-methyl-1-propanone (Irgacure 2959, I2959)
and exposed to ultraviolet light (Black Ray, Redding, CA,
USA) for 10 min. These encapsulation conditions have











































previously been used for the encapsulation of a variety of
mammalian cells.54
hESCs were added to the precursor solution at a concentra-
tion of 0.5–1 6 107 cells ml21. A volume of 30 ml of the cells–
HA mixture was poured into each micro-bioreactor well, and
photopolymerized (using y10 mW cm22 UV light, BlackRay)
for 10 min. Cell–gel constructs were cultivated in growth
medium (for proliferation), and endothelial cell medium (for
differentiation) (PromoCell, Heidelberg, Germany). In some
studies, medium was supplemented with 100 ng ml21 hVEGF
(R&D systems, Minneapolis, MN, USA).
Immunofluorescence
Cells were fixed in situ with accustain (Sigma–Aldrich, St.
Louis, MO, USA) for 25 min at room temperature. Cells were
stained for 1 h with the first antibody and then for 30 min with
a secondary antibody, at room temperature. The wells were
rinsed three times with PBS without calcium and magnesium
(Invitrogen Corp., Carlsbad, CA, USA). DAPI (2 mg ml21;
Sigma–Aldrich) was added to the last rinse. C2C12 cells were
stained for monoclonal Tropomyosin (Sigma–Aldrich). hESCs
were stained either for smooth muscle actin (1 : 20; Dako, Troy
Michigan, USA), or Oct4 (1 : 50; R&D Systems, Minneapolis,
MN, USA). For secondary staining, Cy3 or the FITC-
conjugated antibody (1 : 50; Sigma–Aldrich, St. Louis, MO,
USA) were used. Cardiomyocytes were stained for anti-rabbit
Troponin I and the FITC-conjugated secondary antibody
(both from Chemicon International, Temecula, CA, USA).
The immuno-labeled cells were examined using a fluorescence
microscope (Axiomat, Zeiss, Thornwood, NY, USA).
Data acquisition and analysis
The percent of differentiated and undifferentiated cells were
evaluated by an imaging acquisition program written using
scripts available in MATLAB, and MATLAB imaging toolbox
(The MathWorks, Natick, MA, USA). Images of the entire
micro-bioreactor well area (3.5 mm diameter) were acquired as
a series of images at 56 magnification for the nuclei (DAPI)
and two other markers (cytoplasmic and nuclear intracellular
markers). From the DAPI image, the coordinates of the pixel
of each nucleus were acquired and stored. The intensity of the
pixels corresponding to the DAPI coordinates in the other
two images was used to evaluate the existence of nuclear
transcription factors. The intensity of the cytoplasmic staining
fluorescence was evaluated by considering the intensity of
pixels within the ellipsoid corona centered in the nucleus and
an area 50% bigger in size. Processed data were then used to
count the number of nuclei and evaluate the fraction of cells
expressing a specific marker. Graphical representation of data
(dot plots, histograms) and statistical evaluation of signal
intensities were performed by importing data into a free flow
cytometry data analysis program (WinMDI 2.8).
Conclusions
Stem cell biology is increasingly relying on advanced
technologies that provide better cell culture microenviron-
ments and enable control over multiple molecular and physical
regulatory signals. These enabling technologies are of parti-
cular interest to hESCs, because of the complexity of their
regulatory pathways, and uncontrolled variables associated
with traditional culture methods. We have developed a micro-
bioreactor array that combines the advantages of microarrays
with those of bioreactors, and provides a means to study the
growth and differentiation of hESCs under controlled condi-
tions and in a multiarray setting. The device is the size of a
microscope slide and contains twelve independent micro-
bioreactors perfused with culture medium. The design is
flexible, as it allows 2D and 3D cell culture under variable
levels of hydrodynamic shear and mass transport, which were
characterized by computational methods. To demonstrate the
operation of the MBA, we cultured C2C12 cells, rat cardiac
myocytes and hESCs within the system. A system for
automated in situ image analysis of the expression of cell
differentiation markers has also been developed and used to
investigate the effects of cell density and flow regime on
vascular differentiation of hESCs. This device can thus serve as
a tool for studying hESCs in the context of their environment.
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